IL1B and cardiac hypertrophy: In vitro and in vivo models of cardiac hypertrophy, the expression levels of pyroptosis-related factors were significantly increased (66), downregulation of Caspase-1 and IL-1β expression by Caspase-1 inhibitors attenuates angiotensin II (Ang II) -induced cardiac hypertrophy (78).